Comorbid Addiction and Major Mental Illness in Europe: A Narrative Review

REFERENCES

• Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia. A prospective community study. J Nerv Ment Dis. 1989; 177:408–414.
   PubMed Web of Science ®Google Scholar
• Drake RE, Wallach MA. Substance abuse among the chronic mentally ill. Hosp Community Psychiatry. 1989; 40:1041–1046.
   PubMedGoogle Scholar
• Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 2001; 52:469–476.
   PubMed Web of Science ®Google Scholar
• Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res. 2002; 54:253–264.
   PubMed Web of Science ®Google Scholar
• Margolese HC, Carlos Negrete J, Tempier R, Gill K. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use. Schizophr Res. 2006; 83:65–75.
   PubMed Web of Science ®Google Scholar
• Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002; 63:892–909.
   PubMed Web of Science ®Google Scholar
• Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzin LB. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res. 1996; 20:145–151.
   PubMed Web of Science ®Google Scholar
• Prince JD, Akincigil A, Hoover DR, Walkup JT, Bilder S, Crystal S. Substance abuse and hospitalization for mood disorder among Medicaid beneficiaries. Am J Public Health. 2009; 99:160–167.
   PubMed Web of Science ®Google Scholar
• Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA. Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry. 1995; 152:856–861.
   PubMed Web of Science ®Google Scholar
• Bartoli F, Carrà G, Brambilla G, et al. Association between depression and non-fatal overdoses among drug users: a systematic review and meta-analysis. Drug Alcohol Depend. 2014; 134:12–21.
   PubMed Web of Science ®Google Scholar
• Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS. 2005;19(Suppl 3):S26–S33.
   Google Scholar
• Carrà G, Montomoli C, Monti MC, Clerici M. Does HIV serostatus affect outcomes of dually diagnosed opiate dependents in residential treatment? Epidemiol Psichiatr Soc. 2008; 17:77–81.
   PubMed Web of Science ®Google Scholar
• Fazel S, Gulati G, Linsell L, Geddes JR, Grann M. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009; 6:e1000120.
   PubMed Web of Science ®Google Scholar
• Lamb HR, Weinberger LE. Persons with severe mental illness in jails and prisons: a review. Psychiatr Serv. 1998; 49:483–492.
   PubMed Web of Science ®Google Scholar
• Curran GM, Sullivan G, Williams K, et al. Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann Emerg Med. 2003; 41:659–667.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Co-morbid Substance Use and Mental Disorders in Europe: A Review of the Data. EMCDDA Papers. Luxembourg: Publications Office of the European Union; 2013.
   Google Scholar
• Carrà G, Johnson S. Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review. Soc Psychiatry Psychiatr Epidemiol. 2009; 44:429–447.
   PubMed Web of Science ®Google Scholar
• Mueser KT, Yarnold PR, Bellack AS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand. 1992; 85:48–55.
   PubMed Web of Science ®Google Scholar
• Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62:629–640.
   PubMed Web of Science ®Google Scholar
• Furr-Holden CDM, Anthony JC. Epidemiologic differences in drug dependence: a US–UK cross-national comparison. Soc Psychiatry Psychiatr Epidemiol. 2004; 38:165–172.
   Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction Web site. Available at: http://www.emcdda.europa.eu/. Accessed March 14, 2014.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2014: Trends and Developments. Luxembourg: Publications Office of the European Union; 2014.
   Google Scholar
• Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011; 21:655–679.
   PubMed Web of Science ®Google Scholar
• Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64:566–576.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64:830–842.
   PubMed Web of Science ®Google Scholar
• Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004; 61:807–816.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. EU drugs strategy (2005–2012). Available at: http://www.emcdda.europa.eu/html.cfm/index6790EN.html. Accessed March 14, 2014.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Co-morbidity—drug use and mental disorders. Available at: http://www.emcdda.europa.eu/html.cfm/index36329EN.html. Published 2005. Accessed March 14, 2014.
   Google Scholar
• Carrà G, Johnson S, Bebbington P, et al. The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC). Eur Arch Psychiatry Clin Neurosci. 2012; 262:607–616.
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA. 1990; 264:2511–2518.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996; 66:17–31.
   PubMed Web of Science ®Google Scholar
• Cuffel BJ, Shumway M, Chouljian TL, MacDonald T. A longitudinal study of substance use and community violence in schizophrenia. J Nerv Ment Dis. 1994; 182:704–708.
   PubMed Web of Science ®Google Scholar
• Mueser KT, Essock SM, Drake RE, Wolfe RS, Frisman L. Rural and urban differences in patients with dual diagnosis. Schizophr Res. 2001; 48:93–107.
   PubMed Web of Science ®Google Scholar
• Lambert MT, Griffith JM, Hendrickse W. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center. Psychiatr Serv. 1996; 47:1104–1107.
   PubMed Web of Science ®Google Scholar
• Mowbray CT, Ribisl KM, Solomon M, Luke DA, Kewson TP. Characteristics of dual diagnosis patients admitted to an urban, public psychiatric hospital: an examination of individual, social, and community domains. Am J Drug Alcohol Abuse. 1997; 23:309–326.
   PubMed Web of Science ®Google Scholar
• Drake RE, Alterman AI, Rosenberg SR. Detection of substance use disorders in severely mentally ill patients. Community Ment Health J. 1993; 29:175–192.
   PubMed Web of Science ®Google Scholar
• Goldfinger SM, Schutt RK, Seidman LJ, Turner WM, Penk WE, Tolomiczenko GS. Self-report and observer measures of substance abuse among homeless mentally ill persons in the cross-section and over time. J Nerv Ment Dis. 1996; 184:667–672.
   PubMed Web of Science ®Google Scholar
• Potvin S, Sepehry AA, Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med. 2006; 36:431–440.
   PubMed Web of Science ®Google Scholar
• Department of Health. Mental Health Policy Implementation Guide: Dual Diagnosis Good Practice Guide. London: Department of Health Publications; 2012. Available at: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/dh_4009058. Accessed March 14, 2014.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2006: Selected Issues. Luxembourg: Office for Official Publications of the European Communities; 2006.
   Google Scholar
• Jané-Llopis E, Anderson P. Mental Health Promotion and Mental Disorder Prevention. A Policy for Europe. Nijmegen, The Netherlands: Radboud University Nijmegen; 2005.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2011: The State of the Drugs Problem in Europe. Luxembourg: Publications Office of the European Union; 2011.
   Google Scholar
• EU Action Plan on Drugs 2013–2016 (2013/C 351/01). 30 November 2013. Official Journal of the European Union C 351/1.
   Google Scholar
• Becker I, Vázquez-Barquero JL. The European perspective of psychiatric reform. Acta Psychiatr Scand Suppl. 2001;(410):8–14.
   PubMedGoogle Scholar
• Caldas de Almeida JM, Killaspy H. Long-term mental health care for people with severe mental disorders. Available at: http://ec.europa.eu/health/mental_health/docs/healthcare_mental_disorders_en.pdf. Published 2011. Accessed March 14, 2014.
   Google Scholar
• European Communities. Green Paper—Improving the Mental Health of the Population: Towards a Strategy on Mental Health for the European Union. Brussels: European Communities; 2005. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52005DC0484. Accessed March 14, 2014.
   Google Scholar
• Drake RE, Mueser KT, Brunette MF, McHugo GJ. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J. 2004; 27:360–374.
   PubMed Web of Science ®Google Scholar
• De Witte NA, Crunelle CL, Sabbe B, Moggi F, Dom G. Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. Eur Addict Res. 2013; 20:105–114.
   PubMed Web of Science ®Google Scholar
• Cleary M, Hunt G, Matheson S, Siegfried N, Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev. 2008;(1):CD001088.
   PubMedGoogle Scholar
• Abou Saleh M, Crome I. National Institute for Health and Clinical Excellence (NICE) guideline: psychosis with coexisting substance misuse. Addiction. 2012; 107:1–3.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) Regional Office for Europe. Policies and Practices for Mental Health in Europe—Meeting the Challenges. Copenhagen: WHO Regional Office for Europe; 2008. Available at: http://www.euro.who.int/__data/assets/pdf_file/0006/96450/E91732.pdf. Accessed March 14, 2014.
   Google Scholar
• Baldacchino A, Greacen T, Hodges CL, et al. Nature, level and type of networking for individuals with dual diagnosis: a European perspective. Drugs Educ Prev Policy. 2011; 18:393–401.
   Web of Science ®Google Scholar
• Baldacchino A. Co-morbid substance misuse and mental health problems: policy and practice in Scotland. Am J Addict. 2007; 16:147–159.
   PubMed Web of Science ®Google Scholar
• Cortini E, Clerici M, Carrà G. Is there a European approach to drug-free therapeutic communities? A narrative review. J Psychopathol. 2013; 19:27–33.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Co-morbidity. Available at: http://www.emcdda.europa.eu/html.cfm/index34901EN.html. Published 2004. Accessed March 14, 2014.
   Google Scholar
• Gual A. Dual diagnosis in Spain. Drug Alcohol Rev. 2007; 26:65–71.
   PubMed Web of Science ®Google Scholar
• Hintz T, Mann K. Co-occurring disorders: policy and practice in Germany. Am J Addict. 2006; 15:261–267.
   PubMed Web of Science ®Google Scholar
• Kendall T, Tyrer P, Whittington C, Taylor C; Guideline Development Group. Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance. BMJ. 2011; 342:d1351.
   Google Scholar
• Carrà G, Clerici M. Dual diagnosis—policy and practice in Italy. Am J Addict. 2006; 15:125–130.
   PubMed Web of Science ®Google Scholar
• MacGabhann L, Scheele A, Dunne T, et al. Mental Health and Addiction Services and the Management of Dual Diagnosis in Ireland. Dublin: National Advisory Committee on Drugs (NACD); November 2004. Available at: http://www.nacd.ie/publications/treatment_dual_diagnosis.html. Accessed March 14, 2014.
   Google Scholar
• Cotto JH, Davis E, Dowling GJ, Elcano JC, Staton AB, Weiss SRB. Gender effects on drug use, abuse, and dependence: a special analysis of results from the national survey on drug use and health. Gend Med. 2010; 7:402–413.
   PubMed Web of Science ®Google Scholar
• Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res. 2004; 67:157–166.
   PubMed Web of Science ®Google Scholar
• Carrà G, Bartoli F, Crocamo C, Brady KT, Clerici M. Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis. J Affect Disord. 2014; 167:125–135. doi: 10.1016/j.jad.2014.05.066.
   PubMed Web of Science ®Google Scholar
• Wallace C, Mullen PE, Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry. 2004; 161:716–727.
   PubMed Web of Science ®Google Scholar
• Jones RM, Lichtenstein P, Grann M, Långström N, Fazel S. Alcohol use disorders in schizophrenia: a national cohort study of 12,653 patients. J Clin Psychiatry. 2011; 72:775–779.
   PubMed Web of Science ®Google Scholar
• Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients epidemiology and impact on antiretroviral therapy. Drugs. 2006; 66:769–789.
   PubMed Web of Science ®Google Scholar
• Kerfoot KE, Rosenheck RA, Petrakis IL, et al. Substance use and schizophrenia: adverse correlates in the CATIE study sample. Schizophr Res. 2011; 132:177–182.
   PubMed Web of Science ®Google Scholar
• Perkonigg A, Settele A, Pfiste, H, et al. Where have they been? Service use of regular substance users with and without abuse and dependence. Soc Psychiatry Psychiatr Epidemiol. 2006; 41:470–479.
   PubMed Web of Science ®Google Scholar
• Clark HW, Power AK, Le Fauve CE, Lopez EI. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat. 2008; 34:3–13.
   PubMed Web of Science ®Google Scholar
• Jacobi F, Wittchen HU, Holting C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004; 34:597–611.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2005 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies; 2006. DHHS Publication No. (SMA) 06–4194. NSDUH Series H-30.
   Google Scholar
• Mojtabai R. Use of specialty substance abuse and mental health services in adults with substance use disorders in the community. Drug Alcohol Depend. 2005; 78:345–354.
   PubMed Web of Science ®Google Scholar
• Cantwell R, Scottish Comorbidity Study Group. Substance use and schizophrenia: effects on symptoms, social functioning and service use. Br J Psychiatry. 2003; 182:324–329.
   PubMed Web of Science ®Google Scholar
• Weaver T, Madden P, Charles V, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003; 183:304–313.
   PubMed Web of Science ®Google Scholar
• Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62:629–640.
   PubMed Web of Science ®Google Scholar
• Grella CE, Karno MP, Warda US, Moore AA, Niv N. Perceptions of need and help received for substance dependence in a national probability survey. Psychiatr Serv. 2009; 60:1068–1074.
   PubMed Web of Science ®Google Scholar
• Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007; 86:214–221.
   PubMed Web of Science ®Google Scholar
• Carrà G, Scioli R, Monti MC, Marinoni A. Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders. Eur Addict Res. 2006; 12:96–101.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2009 National Survey on Drug Use and Health: Mental Health Findings. Rockville, MD: Center for Behavioral Health Statistics and Quality; 2010.
   Google Scholar
• Ducharme L, Knudsen H, Roman P. Availability of integrated care for co-occurring substance abuse and psychiatric conditions. Community Ment Health J. 2006; 42:363–375.
   PubMed Web of Science ®Google Scholar
• Timko C, Dixon K, Moos R. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems. Ment Health Serv Res. 2005; 7:229–242.
   PubMedGoogle Scholar
• McGovern MP, Lambert-Harris C, Gotham HJ, Claus RE, Xie H. Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems. Adm Policy Ment Health. 2014; 41:205–214.
   PubMed Web of Science ®Google Scholar
• Johnson S. Dual diagnosis of severe mental illness and substance misuse: a case for specialist services? Br J Psychiatry. 1997; 171:205–208.
   PubMed Web of Science ®Google Scholar
• Weaver T, Renton A, Stimson G, Tyrer P. Severe mental illness and substance misuse. BMJ. 1999; 318:137–138.
   PubMed Web of Science ®Google Scholar